Galectin 10 Protein (AA 1-142) (His tag)

Produktnummer ABIN667436

Produktdetails

Target: Galectin 10 (CLC) (Charcot-Leyden Crystal Protein (CLC))

Protein-Typ: Recombinant

Proteineigenschaft: AA 1-142

Spezies: Human

Quelle: Escherichia coli (E. coli)

Aufreinigungstag / Konjugat: Dieses Galectin 10 Protein ist gelabelt mit His tag.

Applikation: SDS-PAGE (SDS)

Produktmerkmale: CLC, 1-142aa, Human, His tag, E.coli

Reinheit: > 90 % by SDS - PAGE

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/ml (determined by Bradford assay)

Buffer: Liquid. In 20mM Tris-HCl buffer (pH 8.0) containing 1mM DTT, 10% glycerol, 0.1M NaCl

Lagerung: 4 °C

Antigendetails

Target: Galectin 10 (CLC) (Charcot-Leyden Crystal Protein (CLC))

Andere Bezeichnung: CLC (CLC Produkte)

Synonyme: GAL10 Protein, Gal-10 Protein, LGALS10 Protein, LGALS10A Protein, LPPL_HUMAN Protein, Clcp Protein, gal-10 Protein, Bsf3 Protein, CLC Protein, GAL 10 Protein, Gal-8 Protein, Gal8 Protein, Charcot-Leyden crystal galectin Protein, Charcot-Leyden crystal protein Protein, cardiotrophin-like cytokine factor 1 Protein, avian beta-defensin 10 Protein, CLC Protein, Clc Protein, Clcf1 Protein, AvBD10 Protein

Hintergrund: Eosinophil lysophospholipase (CLC), also known as Galectin 10, act on biological membranes to regulate the multifunctional lysophospholipids. CLC is a lysophospholipase expressed in eosinophils and basophils. It hydrolyzes lysophosphatidylcholine to glycerophosphocholine and a free fatty acid. This protein may possess carbohydrate or IgE-binding activities. It is both structurally and functionally related to the galectin family of beta-galactoside binding proteins. It may be associated with inflammation and some myeloid leukemias. Recombinant human CLC protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography techniques. Synonyms: Eosinophil lysophospholipase, Galectin 10, Gal-10, GAL10, LGALS10, LGALS10A, LPPL. NCBI no.: NP_001819

Molekulargewicht: 18.6 kDa (162aa) confirmed by MALDI-TOF

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response